Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Pfizer aligns with Merck KGaA in oncology

Country: Germany

Pfizer Inc has signalled its determination to stay ahead in oncology by agreeing to pay Merck KGaA up to $2.85 billion for rights to the German company’s early-stage checkpoint inhibitor and collaborate on up to 20 other immuno-oncology programmes.

Read more

AstraZeneca highlights oncology

Country: United Kingdom

AstraZeneca Plc has identified oncology as a key business segment as the company takes steps to restore revenue growth and maintain its independence. By 2020 it expects to bring six new cancer medicines to patients.

Read more

Gene therapy gets ‘breakthrough’ status

Country: United States

Read more

FDA approves Lemtrada for MS

Country: United States

Read more

ArGEN-X gives post IPO update

Country: Netherlands

Read more

Chapter 11 for Dendreon

Country: United States

Read more

Evotec confirms 2014 guidance

Country: Germany

Read more

Series A money for Histide of Switzerland

Country: Switzerland

Read more

Circassia says recruitment on track for trial

Country: United Kingdom

Read more

MorphoSys expands platform; revises forecast

Country: Germany

Read more

Genmab lifted by daratumumab milestones

Country: Denmark

Read more

Cardio3 BioSciences buys device company

Country: Belgium

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Commentary- A greater patient voice in drug development by Richard Pops

CommentaryRichardPopsOct2014.pdf

Highlights of the October 2014 MedNous issue

The October 2014 MedNous features:

Latest Mednous cover
  • Financial Strategy
    Why European biopharma
    is starved for capital
  • Oncology Review
    New agents fight
    B-cell malignancies
  • Commentary
    Collaboration to deliver
    superior value to patients
    by Roch Doliveux
  • Commentary
    A greater patient voice in drug development
    By Richard Pops
  • Regulatory
    EMA to make clinical data public
  • Regulatory
    Nobel Prize awarded for brain research

The latest MedNous journal. Subscribe to download.

Recent Appointments